Page 11 - Avoid Food and Drug Interactions
P. 11

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved.  Disclosures

© 2019 ASPEN | American Society for Parenteral and Enteral Nutrition. All Rights Reserved.  • In the past year I have been a speaker and consultant for
                                                                                              Fresenius Kabi and have received honoraria and consultant fees.

                                                                                            • I have also received a consultant fee from Baxter Healthcare from
                                                                                              participation .in a Technical Advisory Board

                                                                                                                                                                                                                    17

                                                                                            Learning Objectives

                                                                                                Upon completion of this session, the learner will be able to….

                                                                                            1. Explain why PN should not be avoided
                                                                                            2. Describe best practices for the appropriate use of PN
                                                                                            3. Improve the safety and efficacy of PN

                                                                                                                                                                                                                    18

                                                                                                                                                                       11
   6   7   8   9   10   11   12   13   14   15   16